Blue Light Phototherapy

Northwestern University

Status: Completed

Conditions: Grover's Disease; Psoriasis Vulgaris

Treatments: Device: Blue light phototherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT04343586

STU00210472

Details and patient eligibility

About

This study will use Blue-light Photo-therapy to treat patients with psoriasis vulgaris and Grover's Disease.

Enrollment: 11 patients

Sex: All

Ages: 18 to 89 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patient's aged 18-89 at time of enrollment
2. Previous diagnosis of psoriasis vulgaris or Grover's disease

Exclusion criteria

1. All Groups: Subjects who are younger than 18 years of age or older than 90 years of age

2. Patients who have received topical or systemic treatment within the prior 2 weeks of planned phototherapy

3. Patients prescribed any of the following drugs for issues not related to their psoriasis or Grover's disease

   • topical steroids
   • calcineurin inhibitors
   • methotrexate
   • retinoids
   • biologic agents

4. Unable to schedule phototherapy sessions

5. We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

11 participants in 1 patient group

Adult treatment arm

Experimental group

Description:

Adults enrolled in the study will receive treatment (blue light phototherapy) on one area of their body affected by psoriasis or Grover's disease. The treatment area (restricted by size of the device) will be compared to untreated areas affected by disease on the same patient.

Treatment:

Device: Blue light phototherapy